Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H14N6 |
Molecular Weight | 230.2691 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)N\N=C1/CCC2=C(C=CC=C12)C(N)=N
InChI
InChIKey=CYPGNVSXMAUSJY-CXUHLZMHSA-N
InChI=1S/C11H14N6/c12-10(13)8-3-1-2-7-6(8)4-5-9(7)16-17-11(14)15/h1-3H,4-5H2,(H3,12,13)(H4,14,15,17)/b16-9+
Sardomozide (previously known as SAM486A or CGP-48664) was developed as an inhibitor of S-adenosyl-methionine-decarboxylase, a key enzyme for polyamine biosynthesis. Sardomozide possessed the broad-spectrum antiproliferative and antitumor activity. The drug participated in a phase II clinical trial as a monotherapy in patients with refractory or relapsed non-Hodgkin's lymphoma. In Phase II clinical trial in patients with metastatic melanoma, the drug didn’t have significant therapeutic potential. The further development of this drug was discontinued.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
4-Amidinoindan-1-one 2'-amidinohydrazone: a new potent and selective inhibitor of S-Adenosylmethionine decarboxylase. | 1993 Jul 23 |
|
CGP 48664, a potent and specific S-adenosylmethionine decarboxylase inhibitor: effects on regulation and stability of the enzyme. | 1997 Feb 15 |
|
Inhibition of multidrug-resistant HIV-1 by interference with cellular S-adenosylmethionine decarboxylase activity. | 2006 Sep 15 |
|
Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma. | 2009 Jul |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14977828
Forty-one previously treated patients with either diffuse large cell, follicular, or peripheral T-cell NHL were treated i.v. with 100 mg/m(2) SAM486A (SARDOMOZIDE) as a daily 1-h infusion for 5 days repeated every 3 weeks. Treatment was continued for a total of eight cycles or until disease progression.
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2076
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
||
|
NCI_THESAURUS |
C2090
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C1673
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
PRIMARY | |||
|
1443105-76-7
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
ALTERNATIVE | |||
|
CHEMBL65789
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
PRIMARY | |||
|
DTXSID40869976
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
PRIMARY | |||
|
149400-88-4
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
PRIMARY | |||
|
300000036894
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
PRIMARY | |||
|
7678
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
PRIMARY | |||
|
CEB05S0B9I
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
PRIMARY | |||
|
9576789
Created by
admin on Sat Dec 16 16:20:13 GMT 2023 , Edited by admin on Sat Dec 16 16:20:13 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)